Triple S Ventures Celebrates Strategic Investment by Alchemist Doha in Denovo Sciences
Triple S Ventures is proud to announce that Alchemist Doha, a leading innovation and equity vehicle in Qatar has made a strategic investment in Denovo Sciences, one of the most promising AI-driven drug discovery startups from our portfolio.
Denovo Sciences is a deep technology company revolutionizing drug development through its proprietary reinforcement learning platform, which designs novel therapeutics without relying on massive training datasets. This approach is especially powerful in targeting complex and previously “undruggable” diseases such as cancer and neurological disorders.
The investment from Alchemist Doha is the result of a global collaboration that began with Triple S Ventures facilitating early connections between Denovo and the broader Alchemist network. These relationships were further deepened through a series of engagements in Armenia, Palo Alto, and most recently, Qatar.
“We are thrilled to witness this partnership come to life between Denovo Sciences and Alchemist Doha,” said Avag Simonyan, Founding Partner at Triple S Ventures. “This moment reflects not only Denovo’s scientific excellence, but also the power of building bridges across innovation ecosystems—from Armenia to Silicon Valley to Qatar. We see this as just the beginning of a deeper, long-term collaboration between Triple S Ventures, Alchemist, and Alchemist Doha.”
Alchemist Doha praised Denovo’s scientific leadership and commitment to integrating into Qatar’s deep tech and life sciences ecosystem. This partnership supports Denovo’s expansion into the MENA region and aligns with Qatar’s national strategy to become a hub for biomedical innovation.
As Denovo enters this next phase of growth, Triple S Ventures remains committed to supporting founders who push the boundaries of science and technology—with the vision and capacity to scale globally.
Triple S Ventures is an early-stage venture capital firm focused on backing exceptional Armenian founders building globally competitive startups. With a deep network across the U.S., Europe, and the Middle East, Triple S helps portfolio companies access capital, talent, and strategic partnerships that unlock scalable growth.
Denovo Sciences is a deep tech company developing an AI-native platform for drug discovery. Using reinforcement learning and molecular simulations, Denovo generates novel compounds optimized for efficacy, safety, and synthetic accessibility—enabling faster and more cost-effective therapeutic development.
Alchemist Doha is a Qatar-based equity vehicle designed to support distinctive tech entrepreneurs in emerging markets. Formed through a partnership between the Alchemist Accelerator and the Qatar Research, Development, and Innovation Council (QRDI), Alchemist Doha leverages Alchemist’s global network and support programs to identify and invest in the most promising founders with compelling products and early market traction. Uniquely positioned within Qatar’s innovation ecosystem, Alchemist Doha also serves as a launchpad for global expansion.
